Cancer Research Institute

The Cancer Research Institute (CRI) is a US-based non-profit organization founded in 1953 by Helen Coley Nauts and Oliver R. Grace with an initial grant from Nelson Rockefeller. Headquartered in New York City, CRI's core mission is to fund and advance immunologically-based cancer treatments. Rather than conducting research directly, CRI collaborates with various institutes and organizations to support groundbreaking cancer research projects. Their primary focus is on harnessing the immune system to combat cancer, aiming to develop effective and innovative immunotherapies.

Notable individuals affiliated with CRI include its founders Helen Coley Nauts and Oliver R. Grace. The organization has garnered support from influential investors and philanthropists, significantly impacting the field of cancer research. Key achievements include funding pivotal studies that have led to the development of successful immunotherapies now in clinical use. CRI's efforts have accelerated the progress of cancer treatment, making substantial contributions to the scientific community and offering hope to patients worldwide.